Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancer.

Nature immunology·2026
Same author

Integrin CD103 reveals a distinct developmental pathway of autoreactive thymocytes in TCR transgenic mice.

Nature communications·2025
Same author

IRE1α-XBP1 safeguards hematopoietic stem and progenitor cells by restricting pro-leukemogenic gene programs.

Nature immunology·2025
Same author

Getting RAMPed up: Neuropeptides boost T helper 1 cell fate.

Immunity·2024
Same author

Corrigendum: XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy.

Genes & development·2024
Same author

Differential Effects of Unfolded Protein Response Pathways on Axon Injury-Induced Death of Retinal Ganglion Cells.

Neuron·2024

Related Experiment Video

Updated: Feb 28, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.8K

T-bet Runs INTERFERence.

Vanja Lazarevic1, Susanne Szabo2, Laurie H Glimcher3

  • 1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Immunity
|June 22, 2017
PubMed
Summary
This summary is machine-generated.

The transcription factor T-bet selectively represses type I interferon (IFN) gene programs. This occurs specifically when cells are stimulated by interferon-gamma (IFN-γ) signaling, impacting immune responses.

More Related Videos

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.7K
piggyBac Transposon System Modification of Primary Human T Cells
10:02

piggyBac Transposon System Modification of Primary Human T Cells

Published on: November 5, 2012

17.9K

Related Experiment Videos

Last Updated: Feb 28, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
08:35

Inducible and Reversible Dominant-negative DN Protein Inhibition

Published on: January 7, 2019

8.8K
Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.7K
piggyBac Transposon System Modification of Primary Human T Cells
10:02

piggyBac Transposon System Modification of Primary Human T Cells

Published on: November 5, 2012

17.9K

Area of Science:

  • Immunology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Type I interferons (IFNs) are crucial for antiviral immunity.
  • Interferon-gamma (IFN-γ) signaling modulates immune cell function.
  • The interplay between different IFN pathways is complex and not fully understood.

Purpose of the Study:

  • To investigate the role of transcription factor T-bet in regulating type I IFN responses.
  • To determine how IFN-γ signaling influences the transcriptional program of type I IFNs.
  • To elucidate the mechanisms by which T-bet controls IFN-γ-mediated immune modulation.

Main Methods:

  • Analysis of gene expression in immune cells.
  • Chromatin immunoprecipitation assays to identify T-bet binding sites.
  • Reporter assays to assess transcriptional activity.
  • Studies using T-bet deficient cell lines and animal models.

Main Results:

  • T-bet was identified as a selective repressor of the type I IFN transcriptional program.
  • T-bet's repressive function is specifically activated in response to IFN-γ signaling.
  • IFN-γ signaling leads to T-bet recruitment to type I IFN gene promoters, inhibiting their transcription.

Conclusions:

  • T-bet plays a critical role in fine-tuning immune responses by selectively suppressing type I IFN production under IFN-γ stimulation.
  • This mechanism highlights a novel regulatory pathway controlling the balance between different types of interferon responses.
  • Understanding this T-bet-mediated repression offers potential therapeutic targets for immune-mediated diseases.